drugset / Trial / NCT03876574
Hepatic Artery Infusion Pump for NPC Liver Metastases
NaSingle-groupOpen-labelTreatment
Summary
A retrospective clinical trial to study the safety and effectiveness of hepatic arterial infusion (HAI) in treating patients who have nasopharyngeal carcinoma metastatic to the liver. Hepatic-direction drug administration improves the control power for intra-hapatic lesions.
Timeline
- Start
- 2011-01-01
- Primary completion
- 2017-12-31
- Completion
- 2017-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Floxuridine | Unknown | 0.15 mg/kg | Other |
| Subject | Gemcitabine | Small molecule | 1 g | Other |
| Background | Dexamethasone | Small molecule | 1 mg/m2 | Other |